Product Program year 2022 Source: CMS Open Payments

Vividex Ink

Device Non-Sterile Ink for Pathology

Open in the dashboard

General payments

$2,700

15 payments

Research payments

$0

0 payments

Through program year 2022, $2,700 in general payments and $0 in research payments were reported against Vividex Ink (Non-Sterile Ink for Pathology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $2,700 15

Breakdown

Who paid General payments · program year 2022
  1. Vector Surgical, LLC $2,700 15 payments
Top recipients General payments · program year 2022
  1. Alexander Gallan Anatomic Pathology · Milwaukee, WI $600 22% · 1 payment
  2. Kimberly Brady MOHS-Micrographic Surgery · Buffalo, NY $300 11% · 2 payments
  3. John Binhlam Dermatology · Brentwood, TN $150 6% · 1 payment
  4. Mark Cripe Surgery · Columbus, OH $150 6% · 1 payment
  5. Jonathan Zager Surgical Oncology · Tampa, FL $150 6% · 1 payment

The top 5 of 14 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Dermatology $900 33% · 6 practitioners
  2. Anatomic Pathology Pathology $600 22% · 1 practitioner
  3. MOHS-Micrographic Surgery Dermatology $600 22% · 3 practitioners
  4. Surgical Oncology Surgery $300 11% · 2 practitioners
  5. Surgery $150 6% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Wisconsin $600 22% · 1 recipient
  2. Pennsylvania $450 17% · 3 recipients
  3. New York $300 11% · 1 recipient
  4. Florida $300 11% · 2 recipients
  5. Ohio $300 11% · 2 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

15 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record